Apotex Corp. Launches Brimonidine Tartrate Ophthalmic Solution, 0.1% in the United States

WESTON, Fla., Sept. 5, 2023 /PRNewswire/ - Apotex Corp. has released its latest ophthalmic product in the United States, announcing today that brimonidine tartrate ophthalmic solution, 0.1% is now available. Brimonidine is an alpha-adrenergic receptor agonist indicated for the reduction...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news